… "How do I know if my symptoms are from 'old age' or Parkinson's?" This is a reasonable and commonly asked question that can be challenging to answer. … and memory or thinking problems -- might be due to getting older. It's also worth considering separate medical …

… LRRK2 (Leucine-Rich Repeat Kinase 2) is a protein thought to be involved in regulating signaling pathways in cells. … for example, where that protein resides in the body or how its levels change in disease. In 2010, MJFF generated … development of this assay from Invitrogen ( www.invitrogen.com ), Neuromab ( www.neuromab.org ) and Epitomics, Inc. ( …

… and spatial orientation. Previous investigation has shown that eight weeks of twice-daily treatment using the … setting was associated with significant reductions in motor and non-motor symptoms in people with Parkinson’s … scales. Effects of the treatment will be evaluated by comparing the change in scores from the pre-treatment …

… Dyskinesia can be confusing. These involuntary movements can … disease. But they are not part of the disease itself. Dyskinesia is a side effect of levodopa — the gold standard … significantly impact quality of life. “If we could control dyskinesia, it would probably be the biggest change in terms …

… J. Fox Foundation (MJFF) devotes our donor-raised dollars to the most promising scientific efforts, which will help … studies that recently received MJFF funding and how they are positioning the field to drive closer to cures … team and organizing their data to share with the research community through the FoxDen data platform . This platform …

… is an individualized disease, meaning everyone’s symptoms and paths are unique, but that doesn’t mean you’re alone. There are common experiences, and many others are on a similar journey. Studies show that, in general, people who have more social …